UPDATED Jul 26, 2024
Explore the French (CAC) Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.
Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
DIM | €173.85 | 5.8% | -38.4% | €16.9b | €216.33 | PE99.8x | E28.8% | 0.4% | ||
ERF | €53.64 | 3.0% | -13.9% | €10.3b | €59.35 | PE31.5x | E18.7% | 0.9% | ||
IPN | €103.20 | 1.8% | -10.3% | €8.5b | €127.40 | PE12.8x | E6.3% | 1.2% | ||
VIRP | €346.50 | 1.3% | 18.9% | €2.9b | €388.00 | PE23.9x | E11.3% | 0.4% | ||
ALCLS | €2.03 | 13.3% | 4.3% | €146.0m | n/a | PS13.1x | E21.0% | n/a | ||
OSE | €7.61 | 10.1% | 134.2% | €165.5m | €11.43 | PS74.3x | E5.9% | n/a | ||
EAPI | €3.35 | 5.0% | -69.1% | €319.9m | €3.30 | PB0.3x | E81.0% | n/a | ||
VETO | €101.20 | 1.3% | 7.9% | €1.2b | €105.83 | PE21.6x | E5.1% | 0.8% | ||
NANO | €4.78 | 3.4% | -34.8% | €226.4m | €11.68 | PS6.3x | E23.7% | n/a | ||
POXEL | €0.57 | 15.0% | -8.4% | €28.3m | n/a | PS18.3x | n/a | n/a | ||
IVA | €2.25 | 1.6% | -38.3% | €117.6m | €13.84 | PS5.1x | E21.0% | n/a | ||
IPH | €2.12 | 1.0% | -24.3% | €171.6m | €6.28 | PS2.8x | E21.8% | n/a | ||
ADOC | €6.42 | 1.4% | 23.0% | €96.6m | €6.30 | PS16x | E63.0% | n/a | ||
DBV | €0.90 | 1.1% | -70.2% | €86.8m | €6.00 | PS6.3x | E21.7% | n/a | ||
ALINT | €0.63 | 10.5% | -55.3% | €4.2m | n/a | PB2.1x | n/a | n/a | ||
ALVAL | €1.35 | 1.8% | -68.6% | €21.2m | €5.10 | PS4.5x | E43.8% | n/a | ||
SIGHT | €0.32 | 1.1% | -53.9% | €33.3m | n/a | PS11.2x | E-34.3% | n/a | ||
ALCOX | €0.18 | 2.9% | -59.6% | €11.3m | €1.00 | PS3.2x | E16.1% | n/a | ||
ABNX | €1.24 | 0.3% | 2.0% | €42.9m | €11.50 | PS9.3x | E-18.7% | n/a | ||
ALVIO | €0.099 | 0.5% | -59.0% | €15.2m | €1.20 | PS8.5x | n/a | n/a | ||
GV | €0.0018 | 0% | -91.3% | €692.9k | n/a | PE-0.07x | n/a | n/a | ||
ALNEV | €0.025 | 0% | -100.0% | €100.7k | n/a | PB0.002x | n/a | n/a | ||
ALPHA | €0.0003 | 0% | -100.0% | €52.0 | n/a | PE-0.000002x | n/a | n/a | ||
PCA | €8.00 | 0% | 11.1% | €109.9m | n/a | PE12.5x | n/a | 0% |